Vericel Corp. (VCEL)
40.95
-0.23
(-0.56%)
USD |
NASDAQ |
Aug 28, 16:00
40.93
-0.02
(-0.05%)
Pre-Market: 20:00
Vericel Cash from Investing (Quarterly) : -2.82M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.82M |
| March 31, 2026 | -4.201M |
| December 31, 2025 | -16.39M |
| September 30, 2025 | -3.377M |
| June 30, 2025 | -9.028M |
| March 31, 2025 | -15.14M |
| December 31, 2024 | -14.65M |
| September 30, 2024 | -21.21M |
| June 30, 2024 | -17.72M |
| March 31, 2024 | -25.45M |
| December 31, 2023 | -8.088M |
| September 30, 2023 | 4.566M |
| June 30, 2023 | -2.408M |
| March 31, 2023 | 2.80M |
| December 31, 2022 | -21.73M |
| September 30, 2022 | -0.811M |
| June 30, 2022 | -2.997M |
| March 31, 2022 | -10.67M |
| December 31, 2021 | 1.885M |
| September 30, 2021 | -2.629M |
| June 30, 2021 | -14.94M |
| March 31, 2021 | 12.19M |
| December 31, 2020 | -25.68M |
| September 30, 2020 | -17.44M |
| June 30, 2020 | 12.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.74M |
| December 31, 2019 | -14.60M |
| September 30, 2019 | 13.37M |
| June 30, 2019 | -3.811M |
| March 31, 2019 | 15.66M |
| December 31, 2018 | -20.45M |
| September 30, 2018 | -45.60M |
| June 30, 2018 | -0.795M |
| March 31, 2018 | -0.184M |
| December 31, 2017 | -0.718M |
| September 30, 2017 | -0.519M |
| June 30, 2017 | -0.203M |
| March 31, 2017 | -0.07M |
| December 31, 2016 | -0.101M |
| September 30, 2016 | -0.333M |
| June 30, 2016 | -1.061M |
| March 31, 2016 | 0.08M |
| December 31, 2015 | -0.097M |
| September 30, 2015 | -0.775M |
| June 30, 2015 | -1.202M |
| March 31, 2015 | -0.318M |
| December 31, 2014 | -0.646M |
| September 30, 2014 | -2.568M |
| June 30, 2014 | 1.036M |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -1.197B |
| ADMA Biologics, Inc. | -2.256M |
| Kyntra Bio, Inc. | 17.67M |
| Conexeu Sciences, Inc. | -0.0301M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.19M |
| Cash from Financing (Quarterly) | 2.692M |
| Free Cash Flow | 61.66M |
| Free Cash Flow Per Share (Quarterly) | 0.2726 |
| Free Cash Flow to Equity (Quarterly) | 16.11M |
| Free Cash Flow to Firm (Quarterly) | 14.42M |
| Free Cash Flow Yield | 2.91% |